Zobrazeno 1 - 10
of 285
pro vyhledávání: '"Brian L, Erstad"'
Autor:
Christopher Edwards, Brian L Erstad
The Indispensable Guide to Interpreting Clinical Laboratory DataBasic Skills in Interpreting Laboratory Data is a comprehensive, in-depth guide to all aspects of lab work that apply to clinical practice. Written by established clinicians and pharmacy
Autor:
Christine M. Groth, Christopher A. Droege, Preeyaporn Sarangarm, Michaelia D. Cucci, Kyle A. Gustafson, Kathryn A. Connor, Kimberly Kaukeinen, Nicole M. Acquisto, Sai Ho J. Chui, Deepali Dixit, Alexander H. Flannery, Nina E. Glass, Helen Horng, Mojdeh S. Heavner, Justin Kinney, William J. Peppard, Andrea Sikora, Brian L. Erstad
Publikováno v:
Critical Care Research and Practice, Vol 2024 (2024)
Objective. Describe continuous infusion (CI) ketamine practices in pediatric intensive care units (PICUs) and evaluate its effect on pain/sedation scores, exposure to analgesics/sedatives, and adverse effects (AEs). Methods. Multicenter, retrospectiv
Externí odkaz:
https://doaj.org/article/356f19f34f504e1ba77f608f1da19c21
Autor:
Jeffrey F. Barletta, Brian L. Erstad
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-8 (2022)
Abstract Obesity is highly prevalent in hospitalized patients admitted with COVID-19. Evidence based guidelines are available for COVID-19-related therapies but dosing information specific to patients with obesity is lacking. Failure to account for t
Externí odkaz:
https://doaj.org/article/06296bd450d84727b36818b8d09199e2
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 3, Iss 4, Pp n/a-n/a (2022)
Abstract Recently there has been increasing interest and debate on the use of tranexamic acid (TXA), an antifibrinolytic drug, in both traumatic and non‐traumatic intracranial hemorrhage. In this review we aim to discuss recent investigations looki
Externí odkaz:
https://doaj.org/article/a6cf084a76954717917a5634f0fec0c2
Autor:
Brian L. Erstad, Jeffrey F. Barletta
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-8 (2021)
Abstract Medications used for supportive care or prophylaxis constitute a significant portion of drug utilization in the intensive care unit. Evidence-based guidelines are available for many aspects of supportive care but drug doses listed are typica
Externí odkaz:
https://doaj.org/article/9597ea7dbb0b43d9b4337e7084be6559
Autor:
Brian L. Erstad, Jeffrey F. Barletta
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-8 (2020)
Abstract Practice guidelines provide clear evidence-based recommendations for the use of drug therapy to manage pain, agitation, and delirium associated with critical illness. Dosing recommendations however are often based on strategies used in patie
Externí odkaz:
https://doaj.org/article/4fbf91cc5b4d4fec8a84d0a572daee97
Autor:
Christine M. Groth, PharmD, BCCCP, FCCM, Christopher A. Droege, PharmD, BCCCP, FCCM, FASHP, Kathryn A. Connor, PharmD, BCCCP, Kimberly Kaukeinen, BA, Nicole M. Acquisto, PharmD, BCCCP, FCCM, FCCP, FASHP, Sai Ho J. Chui, PharmD, BCPS, BCCCP, Michaelia D. Cucci, PharmD, BCPS, BCCCP, Deepali Dixit, PharmD, BCPS, BCCCP, FCCM, Alexander H. Flannery, PharmD, PhD, BCPS, BCCCP, FCCM, Kyle A. Gustafson, PharmD, BCPS, BCCCP, Nina E. Glass, MD, FACS, Helen Horng, PharmD, BCCCP, Mojdeh S. Heavner, PharmD, BCPS, BCCCP, FCCM, Justin Kinney, PharmD, MA, BCCCP, Rachel M. Kruer, PharmD, BCCCP, CNSC, William J. Peppard, PharmD, BCPS, FCCM, Preeyaporn Sarangarm, PharmD, BCPS, BCCCP, Andrea Sikora, PharmD, MSCR, BCPS, BCCCP, FCCM, Velliyur Viswesh, PharmD, BCIDP, BCCCP, Brian L. Erstad, PharmD, MCCM, FCCP, FASHP
Publikováno v:
Critical Care Explorations, Vol 4, Iss 2, p e0633 (2022)
IMPORTANCE:. The response of ICU patients to continuously infused ketamine when it is used for analgesia and/or sedation remains poorly established. OBJECTIVES:. To describe continuous infusion (CI) ketamine use in critically ill patients, including
Externí odkaz:
https://doaj.org/article/9302018256e14d368264b99b8db0b60c
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Background: The use of anti-cytotoxic T-lymphocyte antigen 4 (anti-CTLA4) therapy (ipilimumab) and anti-programmed cell-death 1 (anti-PD1) agents (nivolumab and pembrolizumab) in advanced melanoma have been associated with immune-related adverse even
Externí odkaz:
https://doaj.org/article/2a6de80478f9432aac6eefc0308ae533
Autor:
Yazed S Alsowaida, Ahmad Alamer, Abrar K Thabit, Abdulaziz S Almulhim, Muneerah M Aleissa, Alireza Kalbasi, Khaled Eljaaly, Thamer A Almangour, Brian L Erstad
Publikováno v:
American Journal of Health-System Pharmacy. 80:503-517
Purpose Echinocandins are favored drugs for the treatment of fungal infections. There is growing evidence that obese patients treated with echinocandins have lower exposures due to pharmacokinetic (PK) alterations. We conducted a scoping review to ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::369e707bc88a9ee849c6dac1917a91b9
https://doi.org/10.1093/ajhp/zxad021
https://doi.org/10.1093/ajhp/zxad021
Adverse effects of nonsteroidal anti-inflammatory drugs in critically ill patients: A scoping review
Publikováno v:
American Journal of Health-System Pharmacy. 80:348-358
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f63cfc32a94638f49aa035819441d04e
https://doi.org/10.1093/ajhp/zxac377
https://doi.org/10.1093/ajhp/zxac377